Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2193)
All Articles published online
|
Jul 14, 2005 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Huang YH, Shang BY, Zhen YS. Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule. World J Gastroenterol 2005; 11(26): 3980-3984 [PMID: 15996019 DOI: 10.3748/wjg.v11.i26.3980] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i26/3980.htm |
| Number | Citing Articles |
| 1 |
Natália Aparecida de Paula, Andressa Megumi Niwa, Diogo Campos Vesenick, Carolina Panis, Rubens Cecchini, Ângelo de Fátima, Lúcia Regina Ribeiro, Mário Sérgio Mantovani. Evaluation of the effects of nicorandil and its molecular precursor (without radical NO) on proliferation and apoptosis of 786-cell. Cytotechnology 2013; 65(5): 839 doi: 10.1007/s10616-012-9524-4
|
| 2 |
Lingao Ruan, Zhancheng Xu, Tao Lan, Jinjie Wang, Heng Liu, Chaodong Li, Chaoqing Dong, Jicun Ren. Highly Sensitive Method for Assay of Drug-Induced Apoptosis Using Fluorescence Correlation Spectroscopy. Analytical Chemistry 2012; 84(17): 7350 doi: 10.1021/ac301654g
|
| 3 |
Ajeeth Adhikari, Ben Shen, Christoph Rader. Challenges and opportunities to develop enediyne natural products as payloads for antibody-drug conjugates. Antibody Therapeutics 2021; 4(1): 1 doi: 10.1093/abt/tbab001
|
| 4 |
Yong-Zhan Zhen, Ya-Jun Lin, Bo-Yang Shang, Yong-Su Zhen. Enediyne lidamycin induces apoptosis in human multiple myeloma cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase. International Journal of Hematology 2009; 90(1): 44 doi: 10.1007/s12185-009-0340-3
|
| 5 |
Hong Fang, Shenghua Zhang, Qingfang Miao, Dongsheng Xiong, Yongsu Zhen. Lidamycin induces apoptosis of B-cell lymphoma cells and inhibits xenograft growth in nude mice. Clinical Oncology and Cancer Research 2009; 6(3): 203 doi: 10.1007/s11805-009-0203-y
|
| 6 |
Yue-Ming Wang, Lai-Xing Hu, Zhen-Ming Liu, Xue-Fu You, Sheng-Hua Zhang, Jing-Rong Qu, Zhuo-Rong Li, Yan Li, Wei-Jia Kong, Hong-Wei He, Rong-Guang Shao, Liang-Ren Zhang, Zong-Gen Peng, David W. Boykin, Jian-Dong Jiang.
N-(2,6-Dimethoxypyridine-3-yl)-9-Methylcarbazole-3-Sulfonamide as a Novel Tubulin Ligand against Human Cancer. Clinical Cancer Research 2008; 14(19): 6218 doi: 10.1158/1078-0432.CCR-08-0550
|
| 7 |
Hong Liu, Liang Li, Xing-Qi Li, Xiu-Jun Liu, Yong-Su Zhen. Enediyne lidamycin enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib, in epidermoid carcinoma A431 cells and lung carcinoma H460 cells. Anti-Cancer Drugs 2009; 20(1): 41 doi: 10.1097/CAD.0b013e328318292c
|
| 8 |
Yong-zhan Zhen, Ya-jun Lin, Yi Li, Yong-su Zhen. Lidamycin shows highly potent cytotoxic to myeloma cells and inhibits tumor growth in mice. Acta Pharmacologica Sinica 2009; 30(7): 1025 doi: 10.1038/aps.2009.75
|
| 9 |
Yang-Yang Wang, Liang Li, Xiu-Jun Liu, Qing-Fang Miao, Yi Li, Meng-Ran Zhang, Yong-Su Zhen. Development of a novel multi-functional integrated bioconjugate effectively targeting K-Ras mutant pancreatic cancer. Journal of Pharmaceutical Analysis 2022; 12(2): 232 doi: 10.1016/j.jpha.2021.07.001
|
| 10 |
Andressa Megumi Niwa, Natalia Aparecida de Paula, Diogo Campos Vesenick, Daniele Sartori, Edson Luis Maistro, Lúcia Regina Ribeiro, Mário Sérgio Mantovani. Evaluation of lignan (–)-cubebin extracted fromPiper cubebaon human colon adenocarcinoma cells (HT29). Journal of Toxicology and Environmental Health, Part A 2016; 79(2): 92 doi: 10.1080/15287394.2015.1110067
|
| 11 |
Rafaela Pires Erthal-Michelato, Débora Hipólito Quadreli, Tiago Henrique Zaninelli, Waldiceu Aparecido Verri Junior, Glaura Scantamburlo Alves Fernandes. Lower malathion concentrations reduce testosterone biosynthesis by Leydig TM3 cells in vitro by altering cellular redox profile and inducing oxidative damage. Reproductive Toxicology 2024; : 108595 doi: 10.1016/j.reprotox.2024.108595
|
| 12 |
Jian-lin Yang, Ye Qin, Liang Li, Chu-yu Cao, Qing Wang, Qian Li, Ya-feng Lv, Yanlin Wang. Apoptotic Melanoma B16-F1 Cells Induced by Lidamycin Could Initiate the Antitumor Immune Response in BABL/c Mice. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2016; 23(1): 79 doi: 10.3727/096504015X14478843952942
|
| 13 |
Jing CHEN, Shu-ying WU, Zhi-gang OU-YANG, Yong-su ZHEN. Synergy of gemcitabine and lidamycin associated with NF-κB downregulation in pancreatic carcinoma cells. Acta Pharmacologica Sinica 2008; 29(5): 614 doi: 10.1111/j.1745-7254.2008.00774.x
|
| 14 |
C Xin, S Ye, Y Ming, Z Shenghua, M Qingfang, G Hongxing, S Xu, X Yuanfu, Z Yuan, F Dongmei, L Juanni, G Yingdai, J Lianfang, S Rongguang, Z Zhenping, W Jianxiang, C Tao, Y Chunzheng, X Dongsheng, Z Yongsu. Efficient inhibition of B-cell lymphoma xenografts with a novel recombinant fusion protein: anti-CD20Fab-LDM. Gene Therapy 2010; 17(10): 1234 doi: 10.1038/gt.2010.76
|
| 15 |
Qing-fang Miao, Xiao-yun Liu, Bo-yang Shang, Zhi-gang Ouyang, Yong-su Zhen. An enediyne-energized single-domain antibody-containing fusion protein shows potent antitumor activity. Anti-Cancer Drugs 2007; 18(2): 127 doi: 10.1097/CAD.0b013e3280112779
|
| 16 |
Xiangyi Huang, Yiran Liang, Lingao Ruan, Jicun Ren. Chemiluminescent detection of cell apoptosis enzyme by gold nanoparticle-based resonance energy transfer assay. Analytical and Bioanalytical Chemistry 2014; 406(23): 5677 doi: 10.1007/s00216-013-7611-9
|
| 17 |
Hong Fang, QingFang Miao, ShengHua Zhang, Xin Cheng, DongSheng Xiong, YongSu Zhen. Antitumor effects of an engineered and energized fusion protein consisting of an anti-CD20 scFv fragment and lidamycin. Science China Life Sciences 2011; 54(3): 255 doi: 10.1007/s11427-011-4143-4
|
| 18 |
Sheng-hua Zhang, Hao Zhang, Hong-wei He, Liang Li, Xing-qi Li, Yi-ping Zhang, Rong-guang Shao. Lidamycin up-regulates the expression of thymidine phosphorylase and enhances the effects of capecitabine on the growth and pulmonary metastases of murine breast carcinoma. Cancer Chemotherapy and Pharmacology 2013; 72(4): 777 doi: 10.1007/s00280-013-2253-3
|
| 19 |
Ruijuan Gao, Liang Li, Boyang Shang, Chunyan Zhao, Weijin Sheng, Diandong Li. A Gelatinases‐targeting scFv‐based Fusion Protein Shows Enhanced Antitumour Activity with Endostar against Hepatoma. Basic & Clinical Pharmacology & Toxicology 2015; 117(2): 105 doi: 10.1111/bcpt.12379
|
| 20 |
Lei Hu, ShengHua Zhang, RongGuang Shao, YongSu Zhen. Lidamycin inhibits tumor growth and pulmonary metastasis in murine breast carcinoma and shows synergy with paclitaxel. Chinese Science Bulletin 2013; 58(23): 2805 doi: 10.1007/s11434-013-5732-3
|
| 21 |
Fei-Fei Han, Liang Li, Bo-Yang Shang, Rong-Guang Shao, Yong-Su Zhen. Hsp90 Inhibitor Geldanamycin Enhances the Antitumor Efficacy of Enediyne Lidamycin in Association with Reduced DNA Damage Repair. Asian Pacific Journal of Cancer Prevention 2014; 15(17): 7043 doi: 10.7314/APJCP.2014.15.17.7043
|
| 22 |
Wenguo Jiang, Boyang Shang, Liang Li, Shenghua Zhang, Yongsu Zhen. Construction of a genetically engineered chimeric apoprotein consisting of sequences derived from lidamycin and neocarzinostatin. Anti-Cancer Drugs 2016; 27(1): 24 doi: 10.1097/CAD.0000000000000300
|
| 23 |
Hong-Ying Zhen, Qi-Hua He, Yong-Zhan Zhen, Shu-Ling Wang, Yi-Nan Liu, Wei-Hua Wu, Xiao-Yan Zhang, Ai-Li Lu, Li Shen. Inhibition of mouse embryonic carcinoma cell growth by lidamycin through down-regulation of embryonic stem cell-like genes Oct4, Sox2 and Myc. Investigational New Drugs 2011; 29(6): 1188 doi: 10.1007/s10637-010-9463-x
|
| 24 |
QingFang Miao, BoYang Shang, ZhiGang Ouyang, XiaoYun Liu, YongSu Zhen. Generation and antitumor effects of an engineered and energized fusion protein VL-LDP-AE composed of single-domain antibody and lidamycin. Science in China Series C: Life Sciences 2007; 50(4): 447 doi: 10.1007/s11427-007-0058-5
|
| 25 |
Lin Cai, Hongxia Chen, Qingfang Miao, Shuying Wu, Yue Shang, Yongsu Zhen. Binding capability of the enediyne-associated apoprotein to human tumors and constitution of a ligand oligopeptide-integrated protein. Journal of Biotechnology 2009; 144(2): 142 doi: 10.1016/j.jbiotec.2009.09.001
|
| 26 |
Yanqing Wen, Shuzhen Chen, Zhiyun Meng, Hui Gan, Xiaoxia Zhu, Zhuona Wu, Ruolan Gu, GuiFang Dou. Simultaneous determination of lidamycin enediyne chromophore (LDC) and its aromatized derivative (LDCA) using puerarin as internal standard in rat plasma by LC‐MS/MS. Biomedical Chromatography 2012; 26(3): 400 doi: 10.1002/bmc.1676
|
| 27 |
Gessica Dutra Gonçalves, Simone Cristine Semprebon, Bruna Isabela Biazi, Mario Sergio Mantovani, Glaura Scantamburlo Alves Fernandes. Bisphenol A reduces testosterone production in TM3 Leydig cells independently of its effects on cell death and mitochondrial membrane potential. Reproductive Toxicology 2018; 76: 26 doi: 10.1016/j.reprotox.2017.12.002
|
| 28 |
Andressa Megumi Niwa, Gláucia Fernanda Rocha D′Epiro, Lilian Areal Marques, Simone Cristine Semprebon, Daniele Sartori, Lúcia Regina Ribeiro, Mário Sérgio Mantovani. Salinomycin efficiency assessment in non-tumor (HB4a) and tumor (MCF-7) human breast cells. Naunyn-Schmiedeberg's Archives of Pharmacology 2016; 389(6): 557 doi: 10.1007/s00210-016-1225-7
|